X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (313) 313
Publication (33) 33
Book Chapter (13) 13
Book Review (2) 2
Conference Proceeding (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cfdna (222) 222
index medicus (147) 147
humans (117) 117
oncology (90) 90
cell-free dna (88) 88
female (83) 83
liquid biopsy (73) 73
mutation (61) 61
cancer (60) 60
dna (60) 60
biomarkers (54) 54
plasma (54) 54
deoxyribonucleic acid--dna (51) 51
male (50) 50
adult (47) 47
middle aged (46) 46
circulating tumor dna (42) 42
diagnosis (39) 39
pregnancy (39) 39
aged (38) 38
ctdna (36) 36
genetic aspects (36) 36
analysis (35) 35
blood (35) 35
prognosis (33) 33
serum (32) 32
aneuploidy (31) 31
dna, neoplasm - blood (31) 31
plasma dna (31) 31
biopsy (30) 30
research (30) 30
biomarker (29) 29
dna - blood (27) 27
aged, 80 and over (25) 25
genetic research (25) 25
chemotherapy (24) 24
lung cancer (24) 24
lung-cancer (23) 23
maternal plasma (23) 23
metastasis (23) 23
research paper (22) 22
biomarkers, tumor - blood (21) 21
breast cancer (21) 21
cell biology (21) 21
genetics & heredity (21) 21
mutations (21) 21
obstetrics & gynecology (21) 21
tumors (21) 21
acquired-resistance (20) 20
breast-cancer (20) 20
colorectal cancer (20) 20
pregnant women (20) 20
colorectal-cancer (19) 19
medicine, research & experimental (19) 19
nucleic-acids (19) 19
origin (19) 19
review (19) 19
care and treatment (17) 17
dna, neoplasm - genetics (17) 17
nipt (17) 17
prenatal diagnosis (17) 17
circulating tumor cells (16) 16
dna methylation (16) 16
health aspects (16) 16
kras (16) 16
medicine & public health (16) 16
case-control studies (15) 15
medical laboratory technology (15) 15
next-generation sequencing (15) 15
pathology (15) 15
resistance (15) 15
survival (15) 15
biomarkers, tumor - genetics (14) 14
cell free dna (14) 14
digital pcr (14) 14
heterogeneity (14) 14
medicine (14) 14
prenatal screening (14) 14
quantification (14) 14
tumor dna (14) 14
article (13) 13
biochemistry & molecular biology (13) 13
cell-free nucleic acids - blood (13) 13
circulating dna (13) 13
circulating free dna (13) 13
dna mutational analysis - methods (13) 13
droplet digital pcr (13) 13
free fetal dna (13) 13
gefitinib (13) 13
genetics (13) 13
liquid biopsies (13) 13
methylation (13) 13
neoplasm staging (13) 13
neoplasms. tumors. oncology. including cancer and carcinogens (13) 13
patients (13) 13
prenatal diagnosis - methods (13) 13
prostate cancer (13) 13
screening (13) 13
apoptosis (12) 12
biomarkers - blood (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANALYTICAL CHEMISTRY, ISSN 0003-2700, 03/2018, Volume 90, Issue 6, pp. 3766 - 3774
We describe a technology to perform sizing and concentration analysis of double stranded DNA with a sensitivity of 10 fg/mu L in an operating time of 20 min.... 
CHEMISTRY, ANALYTICAL | PLASMA | INTEGRITY | MARKER | CFDNA | COLORECTAL-CANCER | TUMOR-DNA
Journal Article
Anticancer Research, ISSN 0250-7005, 09/2018, Volume 38, Issue 9, pp. 5121 - 5125
Background/Aim: Seminal plasma cfDNA (scfDNA) was recently proposed as a novel PCa biomarker. Our aim was to evaluate whether scfDNA could discriminate PCa... 
Prostate cancer screening | Spermal cfDNA | Seminal plasma cfDNA | Liquid biopsy | Fluorimetry | Urological biomarkers | Prostate cancer | prostate cancer | EARLY-DIAGNOSIS | PLASMA | BIOMARKER | ONCOLOGY | spermal cfDNA | fluorimetry | prostate cancer screening | liquid biopsy | urological biomarkers
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 06/2018, Volume 57, Issue 24, pp. 6948 - 6948
Ultrasensitive biosensing is made possible by a framework nucleic acids (FNA)‐programmed strategy, designed to develop valence‐controlled signal amplifiers... 
DNA nanostructure | biosensors | framework nucleic acids | valence-engineering | cfDNA
Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 03/2017, Volume 116, Issue 6, pp. 802 - 810
Background: When tumour tissue is unavailable, cell-free DNA (cfDNA) can serve as a surrogate for genetic analyses. Because mutated alleles in cfDNA are... 
GEFITINIB | BIOPSY | EGFR MUTATION | BRAF | lung cancer | LUNG-CANCER | CETUXIMAB | solid tumours | ONCOLOGY | cfDNA | COLORECTAL-CANCER | THERAPIES | NGS | INHIBITORS | ASSOCIATION
Journal Article
Oncotarget, ISSN 1949-2553, 04/2018, Volume 9, Issue 26, pp. 18529 - 18539
Analysis of circulating cell-free DNA (cfDNA) derived from peripheral blood ("liquid biopsy") is an attractive alternative to identify non-small cell lung... 
Liquid biopsy | T790M | CfDNA | NGS | NSCLC
Journal Article
Oncotarget, ISSN 1949-2553, 02/2019, Volume 10, Issue 14, pp. 1388 - 1398
Access to genomic tumor material is required to select patients for targeted therapies. However, tissue biopsies are not always feasible and therefore... 
Genomic profile | Liquid biopsy | CfDNA | WES | Biopsy
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 12, pp. 10259 - 10271
A suitable clinical-grade platform is required for detection of somatic mutations with high sensitivity in cell-free DNA (cfDNA) of patients with solid tumors.... 
DdPCR | Next-generation sequencing | CfDNA | Genotyping | MassARRAY
Journal Article
Oncotarget, ISSN 1949-2553, 11/2018, Volume 9, Issue 90, pp. 36238 - 36249
The mutation status of the and genes in tumor tissue is used to select patients with metastatic melanoma for targeted therapy. Cell-free circulating DNA... 
Metastatic melanoma | NRAS | BRAF | IDYLLA | CfDNA
Journal Article
Translational Cancer Research, ISSN 2218-676X, 02/2018, Volume 7, pp. S171 - S184
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2019, Volume 9, Issue MAY, p. 445
The cell free ribosomal DNA (cf-rDNA) is accrued in the total pool of cell free DNA (cfDNA) in some non-cancer diseases and demonstrates DAMPs characteristics.... 
rDNA | AIM2 | Oxidized cfDNA | TLR9 | Human ribosomal gene | CfDNA | DAMPs | Genetic aspects | Health aspects | DNA | Cancer cells | Cancer | Breast cancer | Research | human ribosomal gene | cfDNA
Journal Article
Journal of Reproduction and Development, ISSN 0916-8818, 2019, Volume 65, Issue 2, pp. 171 - 175
Follicular fluid contains cell-free DNA (cfDNA), which may serve as a useful biomarker of oocyte ability. The present study evaluates whether nuclear and... 
In vitro cultured oocytes | Nuclear cfDNA | Mitochondrial cfDNA | Oocyte quality | AGRICULTURE, DAIRY & ANIMAL SCIENCE | REPRODUCTIVE BIOLOGY | GRANULOSA-CELLS | GROWTH | IMPROVES | FOLLICLE | CARBOHYDRATE-METABOLISM | Original
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 10/2019, Volume 497, pp. 76 - 80
Liquid biopsy consists in the quantification and qualification of circulating cell-free DNA (cfDNA) and tumor-derived DNA (ctDNA) for cancer recognition.... 
Benign prostatic hyperplasia | cfDNA fragment size distribution | Non-invasive prostate cancer diagnosis | Seminal cell-free DNA | CIRCULATING DNA | QUANTIFICATION | TUMOR | MEDICAL LABORATORY TECHNOLOGY | Genetic aspects | Diagnosis | Prostate cancer | Analysis | DNA | Cancer
Journal Article
Journal of Genetic Counseling, ISSN 1059-7700, 10/2016, Volume 25, Issue 5, pp. 965 - 977
The rapid clinical implementation of cell-free DNA (cfDNA) screening, a non-invasive method of prenatal genetic screening, has outpaced research on its social... 
Human Genetics | Public Health | Latinas | Gynecology | Clinical Psychology | Ethics | cfDNA screening | Biomedicine | Spanish-speakers | cfDNA | Prenatal screening | NIPS | NIPT | ethics | prenatal screening
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 09/2019, Volume 141, pp. 36 - 42
Liquid biopsy can quantify and qualify cell-free (cfDNA) and tumour-derived (ctDNA) DNA fragments in the bloodstream. CfDNA quantification and mutation... 
Cell-free DNA | Biomarkers | Liquid biopsy | Non blood cfDNA | Cancer management | Cancer diagnosis | ACQUIRED-RESISTANCE | EGFR MUTATIONS | OCCULT BLOOD | CEREBROSPINAL-FLUID | STOOL DNA | KRAS MUTATIONS | MUTATION STATUS | CIRCULATING TUMOR DNA | ONCOLOGY | PROSTATE-CANCER | COLORECTAL NEOPLASIA | HEMATOLOGY | Thyroid cancer | DNA | Genetic research | Genetic aspects | Diagnosis | Prostate cancer | Cancer
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 20, pp. 15266 - 15274
Ovarian clear cell carcinoma (OCCC) exhibits distinct phenotypes, such as resistance to chemotherapy, poor prognosis and an association with endometriosis.... 
OCCC | Digital PCR | KRAS | CfDNA | PIK3CA
Journal Article
European Urology, ISSN 0302-2838, 09/2018, Volume 74, Issue 3, pp. 283 - 291
Noninvasive biomarkers are needed to guide metastatic castration-resistant prostate cancer (mCRPC) treatment. To clinically qualify baseline and on-treatment... 
Circulating cell-free DNA | cfDNA | Docetaxel | PROSELICA | FIRSTANA | Taxane chemotherapy | Cabazitaxel | CIRCULATING DNA | MITOXANTRONE | BIOMARKER | PHASE-III | SERUM | CHEMOTHERAPY | PREDNISONE | ORIGIN | UROLOGY & NEPHROLOGY
Journal Article